Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Injectable use requires medical supervision
Nevertheless, the relatively short duration of follow-up remains a major limitation because the time required for PDAC to emerge from a normal cell is estimated to be greater than 10 years 31
Who should avoid GHK-CU Wilson's disease or copper metabolism disorders Active malignancies (until more research exists) Pregnancy and breastfeeding Known copper sensitivity or allergy Those unable to maintain sterile injection technique When uncertain, consult a healthcare provider familiar with peptide research
A third widely-cited paper (McCoy 2013, PMID 23055539) the source of the often-repeated "seven orders of magnitude more potent than BDNF" line carries a 2021 Expression of Concern
doi: 10.1016/j.matbio.2012.07.001 94 LiQHXieWXLiXPHuangKTDuZHCongWJet al
